Back
Citius Oncology Stock Price Chart
Sponsored
CTOR
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
1
CTOR
Citius Oncology
Last Price:
1.22
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- The current trend is relatively stagnant and CTOR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Citius Oncology Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.17 | Buy |
20-day SMA: | 1.13 | Buy |
50-day SMA: | 1.39 | Sell |
200-day SMA: | 0 | Buy |
8-day EMA: | 1.16 | Buy |
20-day EMA: | 1.19 | Sell |
50-day EMA: | 1.44 | Sell |
200-day EMA: | 0.03 | Buy |
Citius Oncology Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 45.49 | Sell |
Chaikin Money Flow: | 145001 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.04 - 1.24) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
Citius Oncology Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Citius Oncology Stock
Is Citius Oncology Stock a Buy?
- Citius Oncology share price is 1.19 while CTOR 8-day simple moving average is 1.17, which is a Buy signal.
- The stock price of CTOR is 1.19 while Citius Oncology 20-day SMA is 1.13, which makes it a Buy.
- Citius Oncology 50-day simple moving average is 1.39 while CTOR share price is 1.19, making it a Sell technically.
- CTOR stock price is 1.19 and Citius Oncology 200-day simple moving average is 0.00, creating a Buy signal.
CTOR Technical Analysis vs Fundamental Analysis
Sell
1
Citius Oncology (CTOR)
is a Sell
Is Citius Oncology a Buy or a Sell?
-
Citius Oncology stock is rated a Sell
The current Citius Oncology [CTOR] share price is $1.19. The Score for CTOR is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
Citius Oncology Stock Info
Market Cap:
88.34M
Price in USD:
1.19
Share Volume:
158.95K
Citius Oncology 52-Week Range
52-Week High:
4.42
52-Week Low:
0.93
Sell
1
Citius Oncology (CTOR)
is a Sell
Citius Oncology Share Price Forecast
-
What is the Citius Oncology stock price today?
The Citius Oncology stock price is 1.19 USD today. -
Will CTOR stock go up or go down?
Citius Oncology> share price is forecast to RISE/FALL based on technical indicators -
Is Citius Oncology overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Oncology is overvalued.
Is Citius Oncology Stock a Buy?
- Citius Oncology share price is 1.19 while CTOR 8-day exponential moving average is 1.16, which is a Buy signal.
- The stock price of CTOR is 1.19 while Citius Oncology 20-day EMA is 1.19, which makes it a Sell.
- Citius Oncology 50-day exponential moving average is 1.44 while CTOR share price is 1.19, making it a Sell technically.
- CTOR stock price is 1.19 and Citius Oncology 200-day simple moving average is 0.03, creating a Buy signal.
Technical Analysis of Citius Oncology
Should I short Citius Oncology stock?
- CTOR Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting Citius Oncology is a Sell
- Citius Oncology Relative Strength Index (RSI) is 45.49, which suggest Citius Oncology is oversold
- The Bollinger Bands (25) for Citius Oncology is (1.04 - 1.24), which suggest Citius Oncology is a Buy
- The Bollinger Bands (100) for Citius Oncology is ( - ), which suggest Citius Oncology is a Buy
* Citius Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.